Higher Adherence to Treatment with Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin because of Side Effects in Cancer-Associated Venous Thromboembolism

  1. Van Der Wall, S.J.
  2. Klok, F.A.
  3. Den Exter, P.L.
  4. Barrios, D.
  5. Morillo, R.
  6. Cannegieter, S.C.
  7. Jimenez, D.
  8. Huisman, M.V.
Journal:
HemaSphere

ISSN: 2572-9241

Year of publication: 2018

Volume: 2

Issue: 1

Type: Article

DOI: 10.1097/HS9.0000000000000019 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus